Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI
Abstract Background The aim of this study was to compare contrast enhancement of Magnevist® (gadopentate dimeglumine (Mag)) to that of PEGylated Magnevist®-loaded liposomal nanoparticles (Mag-Lnps) in pancreatic cancer patient-derived xenograft (PDX) mouse model via magnetic resonance imaging (MRI)....
Main Authors: | Kevin Affram, Taylor Smith, Shannon Helsper, Jens T. Rosenberg, Bo Han, Jose Trevino, Edward Agyare |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12645-020-00061-9 |
Similar Items
-
Evaluation of absorbed dose in Gadolinium neutron capture therapy
by: Abdullaeva Gayane, et al.
Published: (2015-02-01) -
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020-12-01) -
Realce por contraste de lesões hepáticas em pacientes com cirrose: estudo cruzado comparativo de dois agentes de contraste para RM realizado em uma única instituição. Resultados preliminares
by: Lauren M. B. Burke, et al.
Published: (2011-06-01) -
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
by: Sandra Roche, et al.
Published: (2020-01-01) -
Distribution of Bupivacaine in Epidural Space
by: Hamid Haji Gholam Saryazdi, et al.
Published: (2018-09-01)